CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read ...

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...

CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 ...

The outlook suggests Rhode Island-based CVS expects to manage a volatile environment that has posed challenges for all three ...

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

CVS Health ( ($CVS) ) has provided an update. On December 9, 2025, CVS Health held its 2025 Investor Day, where it updated ...

Medical experts say getting a yearly flu vaccination is the best way to prevent flu and its potentially serious complications ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

The pharmacy admits to wrong doing and will fork out more than $24 million to the federal government and the remainder will ...

CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and ...

As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...